These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8788277

  • 1. Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue.
    Sciarra F, Monti S, Adamo MV, Palma E, Toscano V, d'Eramo G, di Silverio F.
    Urol Res; 1995; 23(6):387-90. PubMed ID: 8788277
    [Abstract] [Full Text] [Related]

  • 2. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.
    Di Silverio F, Monti S, Sciarra A, Varasano PA, Martini C, Lanzara S, D'Eramo G, Di Nicola S, Toscano V.
    Prostate; 1998 Oct 01; 37(2):77-83. PubMed ID: 9759701
    [Abstract] [Full Text] [Related]

  • 4. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V.
    J Clin Endocrinol Metab; 2001 Apr 01; 86(4):1700-6. PubMed ID: 11297606
    [Abstract] [Full Text] [Related]

  • 5. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S, Di Silverio F, Toscano V, Martini C, Lanzara S, Varasano PA, Sciarra F.
    J Androl; 1998 Apr 01; 19(4):428-33. PubMed ID: 9733145
    [Abstract] [Full Text] [Related]

  • 6. Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
    Di Silverio F, Sciarra A, Monti S, Casale P, Seccareccia F.
    J Urol; 1999 Jan 01; 161(1):128-32. PubMed ID: 10037384
    [Abstract] [Full Text] [Related]

  • 7. Pathology of BPH.
    Di Silverio F, D'Eramo G, Flammia GP, Caponera M, Frascaro E, Buscarini M, Mariani M, Sciarra A.
    Minerva Urol Nefrol; 1993 Dec 01; 45(4):135-42. PubMed ID: 7517581
    [Abstract] [Full Text] [Related]

  • 8. Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.
    Habib FK, Goodman CM, Buck C.
    Urol Res; 1992 Dec 01; 20(4):281-4. PubMed ID: 1380746
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentrations in the human prostate.
    Geller J, Sionit LR, Baird A, Kohls M, Connors KM, Hoffman RM.
    Prostate; 1994 Oct 01; 25(4):206-9. PubMed ID: 7521961
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens.
    Monti S, Di Silverio F, Lanzara S, Varasano P, Martini C, Tosti-Croce C, Sciarra F.
    Steroids; 1998 Oct 01; 63(5-6):362-6. PubMed ID: 9618803
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y, Chisholm GD, Habib FK.
    Br J Cancer; 1993 Jan 01; 67(1):152-5. PubMed ID: 7678977
    [Abstract] [Full Text] [Related]

  • 12. Concentration of the endogenous antiandrogen epitestosterone and androgenic C19-steroids in hyperplastic prostatic tissue.
    Hill M, Hampl R, Petrík R, Stárka L.
    Prostate; 1996 Jun 01; 28(6):347-51. PubMed ID: 8650070
    [Abstract] [Full Text] [Related]

  • 13. Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).
    Sciarra F.
    Ann N Y Acad Sci; 1995 Jun 12; 761():66-78. PubMed ID: 7542859
    [Abstract] [Full Text] [Related]

  • 14. Determination of testosterone and its tissue metabolites (DHT and 3 alpha-diol) in human plasma and prostatic tissue by isotopic dilution mass spectrometry.
    Moneti G, Giovannini MG, Guarna A, Forti G, Salerno R, Magini A, Serio M.
    J Steroid Biochem; 1987 Jun 12; 27(1-3):53-9. PubMed ID: 2447389
    [Abstract] [Full Text] [Related]

  • 15. [Endogenous androgen levels of human prostatic tissues].
    Morioka M, Takeda K, Mitsuhata N, Ohashi T, Ohmori H, Saito T, Kanbegawa A.
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul 20; 58(7):876-85. PubMed ID: 6182032
    [Abstract] [Full Text] [Related]

  • 16. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Pejčić T, Tosti T, Tešić Ž, Milković B, Dragičević D, Kozomara M, Čekerevac M, Džamić Z.
    Prostate; 2017 Jul 20; 77(10):1082-1092. PubMed ID: 28594074
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.